B. Spellberg

Epidemiology · 2001–2019

A researcher in the Science corpus: 11 papers; trusts 1 researcher and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

• Epidemiology — 44 citations into it
• Molecular Biology — 15 citations into it
• Cell Biology — 9 citations into it

Whom B. Spellberg trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Nina Singh
2. Amy S. Lee
3. L. Rice

Who trusts B. Spellberg overall

1. Neil O. Fishman
2. I. Ahmad
3. H. Boucher
4. A. Cheng
5. J. Patterson
6. A. Alanis

Papers from B. Spellberg's perspective

Ordered by how strongly the researchers B. Spellberg trusts endorse each paper. Same corpus, a different order for every researcher.

1. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. (Clinical Infectious Diseases)
2. Zygomycetes in human disease. (Clinical Microbiology Reviews)
3. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. (Clinical Infectious Diseases)
4. Global Challenge of Multidrug-Resistant Acinetobacter baumannii (Antimicrobial Agents and Chemotherapy)
5. Trends in antimicrobial drug development: implications for the future. (Clinical Infectious Diseases)
6. Voriconazole treatment for less-common, emerging, or refractory fungal infections. (Clinical Infectious Diseases)
7. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. (Clinical Infectious Diseases)
8. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. (Journal of Infectious Diseases)
9. Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. (Clinical Infectious Diseases)
10. Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases. (Clinical Infectious Diseases)

Their papers

• Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium (2019) — 925 citations
• Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges (2016) — 956 citations
• The Future of Antibiotics and Resistance (2013) — 645 citations
• Pathogenesis of mucormycosis. (2012) — 722 citations
• Combating antimicrobial resistance: policy recommendations to save lives. (2011) — 736 citations
• Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. (2009) — 4,597 citations
• Nosocomial fungal infections: epidemiology, diagnosis, and treatment. (2007) — 743 citations
• Novel Perspectives on Mucormycosis: Pathophysiology, Presentation, and Management (2005) — 1,367 citations
• Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. (2005) — 1,082 citations
• Trends in antimicrobial drug development: implications for the future. (2004) — 864 citations
• Type 1/Type 2 immunity in infectious diseases. (2001) — 917 citations